Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 235

1.

Heparin-induced thrombocytopenia: temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin.

Lubenow N, Kempf R, Eichner A, Eichler P, Carlsson LE, Greinacher A.

Chest. 2002 Jul;122(1):37-42.

PMID:
12114336
[PubMed - indexed for MEDLINE]
2.

[Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II].

Ganzer D, Gutezeit A, Mayer G, Greinacher A, Eichler P.

Z Orthop Ihre Grenzgeb. 1997 Nov-Dec;135(6):543-9. German.

PMID:
9499523
[PubMed - indexed for MEDLINE]
3.

The management of heparin-induced thrombocytopenia.

Keeling D, Davidson S, Watson H; Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology.

Br J Haematol. 2006 May;133(3):259-69. Erratum in: Br J Haematol. 2006 Aug;134(3):351.

PMID:
16643427
[PubMed - indexed for MEDLINE]
4.

Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia.

Gruel Y, Pouplard C, Nguyen P, Borg JY, Derlon A, Juhan-Vague I, Regnault V, Samama M; French Heparin-Induced Thrombocytopenia Study Group.

Br J Haematol. 2003 Jun;121(5):786-92.

PMID:
12780795
[PubMed - indexed for MEDLINE]
5.

Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients.

Schroder JN, Daneshmand MA, Villamizar NR, Petersen RP, Blue LJ, Welsby IJ, Lodge AJ, Ortel TL, Rogers JG, Milano CA.

Ann Thorac Surg. 2007 Sep;84(3):841-5; discussion 845-6.

PMID:
17720387
[PubMed - indexed for MEDLINE]
6.

Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.

ten Berg MJ, van den Bemt PM, Huisman A, Schobben AF, Egberts TC, van Solinge WW.

Ann Pharmacother. 2009 Sep;43(9):1405-12. doi: 10.1345/aph.1L646. Epub 2009 Aug 18.

PMID:
19690229
[PubMed - indexed for MEDLINE]
7.

Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia.

Fabris F, Luzzatto G, Soini B, Ramon R, Scandellari R, Randi ML, Girolami A.

J Intern Med. 2002 Aug;252(2):149-54.

PMID:
12190890
[PubMed - indexed for MEDLINE]
8.

Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass.

Selleng S, Selleng K, Wollert HG, Muellejans B, Lietz T, Warkentin TE, Greinacher A.

J Thromb Haemost. 2008 Mar;6(3):428-35. Epub 2007 Dec 11.

PMID:
18088340
[PubMed - indexed for MEDLINE]
9.

An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients.

Warkentin TE, Roberts RS, Hirsh J, Kelton JG.

Arch Intern Med. 2003 Nov 10;163(20):2518-24.

PMID:
14609790
[PubMed - indexed for MEDLINE]
10.

Early-onset heparin-induced thrombocytopenia after a 165-day heparin-free interval: case report and review of the literature.

DeEugenio DL, Ruggiero NJ, Thomson LJ, Menajovsky LB, Herman JH.

Pharmacotherapy. 2005 Apr;25(4):615-9.

PMID:
15977921
[PubMed - indexed for MEDLINE]
11.

Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study.

Gettings EM, Brush KA, Van Cott EM, Hurford WE.

Crit Care. 2006;10(6):R161.

PMID:
17109753
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Heparin-induced thrombocytopenia after liver transplantation.

Kaneko J, Sugawara Y, Tamura S, Togashi J, Matsui Y, Makuuchi M.

Transplant Proc. 2008 Jun;40(5):1518-21. doi: 10.1016/j.transproceed.2008.01.069.

PMID:
18589141
[PubMed - indexed for MEDLINE]
13.

Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital.

Ban-Hoefen M, Francis C.

Thromb Res. 2009 Jun;124(2):189-92. doi: 10.1016/j.thromres.2009.01.006. Epub 2009 Feb 4.

PMID:
19195684
[PubMed - indexed for MEDLINE]
14.

Heparin-induced thrombocytopenia in patients administered heparin solely for hemodialysis.

Murray PT, Hursting MJ.

Ren Fail. 2006;28(7):537-9.

PMID:
17050234
[PubMed - indexed for MEDLINE]
15.

Clinical presentation of heparin-induced thrombocytopenia.

Warkentin TE.

Semin Hematol. 1998 Oct;35(4 Suppl 5):9-16; discussion 35-6. Review.

PMID:
9855179
[PubMed - indexed for MEDLINE]
16.

Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes.

Baroletti S, Piovella C, Fanikos J, Labreche M, Lin J, Goldhaber SZ.

Thromb Haemost. 2008 Dec;100(6):1130-5.

PMID:
19132240
[PubMed - indexed for MEDLINE]
17.

Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients.

Wester JP, Haas FJ, Biesma DH, Leusink JA, Veth G.

Intensive Care Med. 2004 Oct;30(10):1927-34. Epub 2004 May 20.

PMID:
15156309
[PubMed - indexed for MEDLINE]
18.

Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Warkentin TE, Greinacher A.

Chest. 2004 Sep;126(3 Suppl):311S-337S. Review. Erratum in: Chest. 2005 Jan;127(1):416.

PMID:
15383477
[PubMed - indexed for MEDLINE]
19.

Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia.

Lewis BE, Wallis DE, Hursting MJ, Levine RL, Leya F.

Chest. 2006 Jun;129(6):1407-16.

PMID:
16778256
[PubMed - indexed for MEDLINE]
20.

Low-molecular-weight heparin-induced thrombocytopenia in a child.

Dager WE, White RH.

Ann Pharmacother. 2004 Feb;38(2):247-50. Epub 2003 Dec 23.

PMID:
14742760
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk